MissionIR

Wednesday Jan 08, 2025 - 2:16 pm

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Paves Cash Runway to Advance CNM-Au8(R) for ALS

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company recently secured a new $10 million debt facility, which enables the payoff of another higher interest rate loan and the finance of operations to…

Friday Jan 03, 2025 - 3:19 pm

InvestorNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Eyes Continued Adoption of Flagship Platform

Thumzup (NASDAQ: TZUP), an emerging leader in social media branding and marketing solutions, has seen tremendous growth in the number of advisers subscribing to its proprietary ad-tech platform. “Our platform’s capability to engage consumers directly through social media and reward them for their endorsements has met with enthusiastic response from a wide spectrum of businesses,” said Thumzup CEO Robert Steele. “This includes retailers, restaurants, home…

Thursday Jan 02, 2025 - 2:35 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Emerging as Key Player in Commodities Market

McEwen Mining (NYSE: MUX) (TSX: MUX) is well-positioned for the next commodity cycle. “Rising commodity prices—particularly in metals critical to green energy—are creating opportunities for investors in mining stocks, even as broader equity markets face potential headwinds from inflation and geopolitical risks. With metal prices climbing and demand for resources surging, companies with diversified portfolios and strong fundamentals are emerging as key players in this…

Friday Dec 27, 2024 - 1:35 pm

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Eyes Opportunities Beyond ‘Year of Significant Progress’

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, was featured in a recent article that discussed the company’s year-end investor webcast, where it provided stakeholders with a comprehensive overview of 2024 milestones and strategic initiatives for 2025. The webcast also highlighted financial developments, including the securing of a $50 million At-The-Market (“ATM”) offering and ongoing strategic efforts to…

Thursday Dec 26, 2024 - 2:37 pm

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R)

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently received additional written guidance and a roadmap from the U.S. Food and Drug Administration’s (“FDA”) Division of Neurology 1 regarding a potential accelerated approval pathway for…

Friday Dec 20, 2024 - 2:57 pm

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Committed to Ensuring Highest Standards in Continued Buntanetap Trials

Annovis Bio (NYSE: ANVS) is a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases. The company’s lead candidate, buntanetap, is an innovative drug that targets multiple pathways involved in neurodegenerative diseases by inhibiting the production of neurotoxic proteins that lead to the death of neurons, thereby slowing or stopping disease progression. A recent article highlights the company’s successful clinical trials and its receipt…

Thursday Dec 19, 2024 - 3:19 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Poised for Growth in Providing Critical Resources for AI Infrastructure

McEwen Mining (NYSE: MUX) (TSX: MUX) was featured in a recent article that discussed the transformation of a nearly 150-year old Japanese firm into the country’s hottest stock amid burgeoning growth in the AI sector. “The current boom in AI has turned a previously little-known Japanese company into a star on the stock market. Fujikura, which has been in existence for the past 139 years,…

Wednesday Dec 18, 2024 - 1:28 pm

InvestorNewsBreaks – Why Thumzup Media Corp. (NASDAQ: TZUP) Is ‘One to Watch’

Thumzup (NASDAQ: TZUP) is at the forefront of modernizing the marketing industry with its unique platform designed to connect advertisers directly with everyday social media users. “The company’s mission is to empower individuals by turning their authentic social media activity into a monetizable asset while providing brands with cost-effective and impactful advertising solutions,” reads a recent article. “Through its flagship Thumzup platform, the company offers…

Thursday Dec 12, 2024 - 2:51 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned to Capitalize on the Rise of AI

McEwen Mining (NYSE: MUX) (TSX: MUX) is poised to benefit amid the growing use of artificial intelligence (“AI”) in everyday life activities. As the use of AI tools trends upward, such as in the job application process among countless others, “The companies behind those AI tools could be basking in the limelight of their innovations, but behind this revolution lies several unsung heroes; including metals…

Monday Dec 09, 2024 - 2:10 pm

InvestorNewsBreaks – Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Waterberg Project Poised for Robust Output Amid Increased Demand

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is emerging as a noteworthy player in the sector as interest in platinum continues to rise. “The company operates the Waterberg PGM Project, a large palladium and platinum deposit located in South Africa. Recently, Platinum Group Metals announced and filed with securities regulators an updated Independent Definitive Feasibility Study (‘2024 DFS’) for the Waterberg Project, which…

Wednesday Nov 27, 2024 - 2:58 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Poised to Tap Explosive Growth of AI Industry

McEwen Mining (NYSE: MUX) (TSX: MUX) is positioned for opportunity as artificial intelligence is rapidly reshaping the landscape of economies around the world. “Estimates indicate that generative AI alone will triple its growth to a total market value of $1.3 trillion in the next decade… As most investors know by now, there is a surge in the demand for energy-guzzling data centers that are designed…

Wednesday Nov 20, 2024 - 1:33 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Poised for Opportunity Amid Rising Demand for ‘AI Metals’

McEwen Mining (NYSE: MUX) (TSX: MUX) was featured in a recent article that discussed the evolution of artificial intelligence (“AI”), spotlighting Geoffrey Hinton’s (“the Godfather of AI”) award of the Nobel Prize in Physics alongside John Hopfield for their groundbreaking work that triggered the development of machine learning, the science behind AI as we know it today. The piece describes early work and systems compared…

Tuesday Nov 19, 2024 - 2:30 pm

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Paving the Way for NDA Submission

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company focused on developing transformative therapies for neurodegenerative disorders, including Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), recently achieved a significant milestone in its drug development process. In early October, the company held a meeting with the U.S. Food and Drug Administration (“FDA”), where it received clearance to proceed with pivotal Phase 3 studies for its…

Friday Nov 15, 2024 - 2:21 pm

InvestorNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Marks Pivotal Step to Enhance Operational Capabilities, Secure Offtake Agreement

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM), the operator and majority owner of the Waterberg Project, recently announced an important collaboration with Ajlan & Bros Mining and Metals Co. to explore establishing a standalone platinum group metals (“PGM”) smelter and base metals refinery (“BMR”) in Saudi Arabia. “This agreement, structured into three distinct phases, marks a pivotal step in the company’s strategy to…

Wednesday Nov 13, 2024 - 2:58 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) – A Gem in the Mining Sector

McEwen Mining (NYSE: MUX) (TSX: MUX) is positioned to benefit from increased investor interest in precious metals as well as growing demand for critical minerals. “McEwen Mining is a gold and silver producer with operations across the Americas, including Nevada, Canada, Mexico, and Argentina. In addition to its core business of precious metals, the company has significant exposure to copper through its 48% ownership of…

Thursday Nov 07, 2024 - 12:57 pm

InvestorNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Moving to Benefit from Increased Demand for PGMs

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is poised to benefit from the automotive industry’s shift toward hybrid and electric vehicles (“EVs”). “A surge in sales of hybrid cars as electric vehicle take-up slows is set to provide an unexpected boost to demand for platinum group metals (‘PGMs’) in the coming years, similar to the extended lifespan now predicted for coal,” reads a…

Tuesday Oct 29, 2024 - 12:51 pm

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Moving Closer to Providing Much-Needed Treatments to Patients

Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering novel therapies for neurodegenerative diseases. Recent clinical trials of the company’s lead compound yielded encouraging results, with buntanetap shown to improve cognition in both Alzheimer’s and Parkinson’s patients. The company also introduced a new crystalline form of buntanetap with improved properties, “offering significant advantages over the less structured, old semi-crystalline form,” according to…

Thursday Oct 24, 2024 - 12:53 pm

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker with FDA Leadership

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently announced an upcoming meeting with U.S. Food and Drug Administration (“FDA”) leadership. The focus is to discuss Clene’s CNM-Au8® biomarker and related clinical and survival data…

Monday Oct 21, 2024 - 1:23 pm

InvestorNewsBreaks – Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Lion Battery Accelerating Development of Next-Gen Technology

Platinum Group Metals (NYSE American: PLG) (TSX: PTM), through its subsidiary Lion Battery, is working to strengthen its foothold in the lithium-sulfur space. With new technologies being researched and developed to rival lithium-ion batteries in terms of efficiency, cost and sustainability, lithium-sulfur batteries could offer advantages. “Lion Battery was jointly formed in 2019 by Platinum Group and Anglo American Platinum to accelerate the development of…

Friday Sep 20, 2024 - 3:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 Drugs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) technology. “Lexaria has recently made strides with glucagon-like peptide-1 (‘GLP-1’) studies. It has reported positive interim results from an animal study on diabetes. This milestone best showcases the potential of its patented technology in not only addressing diabetes…

Friday Sep 20, 2024 - 2:20 pm

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Stands Distinct from Industry Players with Buntanetap

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, secured U.S. patent No. 12,042,482 covering methods for treating traumatic brain injury (“TBI”) and nerve injury with buntanetap, the company’s lead drug candidate. “Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins such as amyloid beta, tau, alpha-synuclein, and TDP43; by inhibiting their translation, the drug…

Friday Sep 13, 2024 - 3:27 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). “Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, 2024. The company reduced certain R&D expenditures and experienced other savings,” reads a recent article. “Most…

Friday Aug 30, 2024 - 2:45 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth

InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company published a report on the expansion of the minor cannabinoid market in 2023. “The report, based on data from Headset, the largest industry dataset, explores the growth, competition and consumer…

Friday Aug 30, 2024 - 2:15 pm

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Expands Team in Continued Focus to Make Meaningful Impact on Lives of AD, PD Patients

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), recently welcomed four seasoned professionals to its executive team. “Annovis Bio is excited about the new additions and confident that these highly experienced professionals will significantly contribute to the company’s mission of developing transformative therapies for neurodegenerative diseases.…

Thursday Aug 29, 2024 - 11:48 am

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Facilitating Global Transition Toward Solar

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation. “With its unique market positioning, Correlate is facilitating the global solar energy transition, offering important additional benefits associated with its adoption, encouraging profitability and overall sustainability while reducing carbon footprint. So far, Correlate has developed,…

Friday Aug 23, 2024 - 3:00 pm

InvestorNewsBreaks – Why Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Is ‘One to Watch’

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (“PGM”) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. “The Waterberg Project is planned as a fully mechanized platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and…

Thursday Aug 22, 2024 - 2:30 pm

InvestorNewsBreaks – PaxMedica Inc. (PXMD) Committed to Global Health, Potential Positive Impact of PAX-101

PaxMedica (OTC: PXMD), a biopharmaceutical company specializing in neurological disorder treatments, is preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration for suramin to treat Human African Trypanosomiasis (“HAT”). “In April 2024, PaxMedica underscored its commitment to global health by responding to an urgent request from Malawi for an emergency release of suramin, demonstrating its dedication to advancing healthcare…

Thursday Aug 22, 2024 - 1:37 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Positioned for Opportunity Amid Unstoppable Trend

Correlate (OTCQB: CIPI) is positioned as a combination of unprecedented levels of government incentives and growing private sector investment funding are pushing a noteworthy shift in energy trends. The momentum shows decentralized electrical energy generation gaining an increasing following according to an MSE Investments report praising the visionary qualities of Correlate Energy. “The distributed energy solutions company recently announced its coming role in co-developing the…

Thursday Aug 22, 2024 - 1:04 pm

InvestorNewsBreaks – SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) Offers Proactive Approach to Growing Rat Problem

SenesTech’s (NASDAQ: SNES) flagship product, Evolve(TM), has repeatedly demonstrated an effective rat control alternative to current market offerings. “The active ingredient in the product has been scientifically proven to reduce rodent fertility, ultimately offering a more proactive approach to addressing the growing rat problem, as opposed to a more reactive approach, as is the case with poisons and traps. The obvious argument is that it’s…

Friday Aug 16, 2024 - 3:03 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089 Showing Great Promise in Treating AMD

InMed Pharmaceuticals (NASDAQ: INM), a clinical stage company developing a pipeline of pharmaceutical drug candidates to treat several diseases with a high unmet medical need, is at the forefront of developing innovative treatment for age-related macular degeneration (“AMD”), with its flagship product INM-089 showing great promise. “AMD is a prevalent eye condition that primarily affects older adults, leading to vision loss in the central part…

Friday Aug 16, 2024 - 2:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Opportunity from First-Ever Work with Tirzepatide Molecule

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently hired a Contract Research Organization (“CRO”) for its third human pilot study. “This marks a milestone for the company, notably since it announced its focus solely on glucagon-like peptide 1 (‘GLP-1’) studies for the 2024 calendar year… This randomized, crossover investigation will evaluate a dual-action GLP-1 + glucose-dependent insulintropic peptide (‘GIP’), specifically…

Friday Aug 16, 2024 - 2:09 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Addressing ‘Significant Problem’ with Resilient Energy Solutions

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is driving scalability in the microgrid energy distribution market. This follows a new partnership between its subsidiary Distributed Energy Capital (“DEC”) and clean energy development innovator Compass Energy that will establish the United States’ first microgrid utility. “The landmark initiative by Distributed Energy Capital and Compass Energy Platform…

Wednesday Aug 14, 2024 - 2:00 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) CEO Showcases Strategic Approach to Industry

McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. McEwen CEO Rob McEwen recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference, where he emphasized the crucial importance of the mining industry to modern civilization and outlined a strategic approach to improving its public perception. “The central theme of McEwen’s speech was…

Friday Jul 12, 2024 - 12:04 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Expanding Solutions to Significant Untapped Market

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is strategically working with partners to help clients facilitate green energy transition and improvements. “Correlate Energy is expanding its renewable energy adoption services into a significant untapped market, thanks to a new corporate partnership, a new federal funding program benefitting low-income communities, and a non-profit insurance company designed…

Thursday Jul 11, 2024 - 2:30 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned as Standout Opportunity for Investors

McEwen Mining’s (NYSE: MUX) (TSX: MUX) share price has shown a remarkable gain of 62.1% over the last 12 weeks, indicating strong momentum and robust performance in the market. “This trend of sustained positive momentum over time is a key indicator of the stock’s potential for continued growth, making it an attractive option for those looking to capitalize on price strength… McEwan Mining’s financial health…

Thursday Jul 11, 2024 - 2:00 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment

InMed (NASDAQ: INM) is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. The company recently released several critical updates regarding its INM-089 therapy treating dry Age-related Macular Degeneration (“AMD”) and its INM-901 small molecule drug candidate targeting Alzheimer’s disease (“AD”). “Recent preclinical data for INM-089 demonstrated significant functional and pathological improvements in an…

Wednesday Jul 10, 2024 - 12:30 pm

InvestorNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Sets New Standard for Accuracy, Reliability in Narcotics Detection

Astrotech (NASDAQ: ASTC), through its subsidiary 1st Detect, is revolutionizing narcotics and explosives trace detection. “With recent approval as a U.S. General Services Administration (‘GSA’) authorized vendor, 1st Detect is poised to expand its impact across government agencies. TRACER 1000 is a cutting-edge detector utilizing ruggedized mass spectrometry technology for superior detection at critical security points. 1st Detect’s commitment to excellence is underscored by its…

Monday Jul 01, 2024 - 12:37 pm

InvestorNewsBreaks – PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones

PaxMedica (OTC: PXMD), a biopharmaceutical company specializing in neurological disorders, is preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for using suramin to treat Human African Trypanosomiasis (“HAT”), a well-established treatment in East Africa for nearly a century. A recent article discussed PaxMedica gearing up for a significant Type C meeting it had with the FDA, which…

Friday Jun 28, 2024 - 2:30 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Helping Companies ‘Beat the Grid for Costs’

Correlate (OTCQB: CIPI) is a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America. “Correlate Energy is a unique source for helping make renewable energy accessible to companies seeking to transition from more carbon-intensive fuels as part of a worldwide effort to forestall the harms of pollution-driven changes to the environment. The company’s focus on solar energy infrastructure, for example, is…

Thursday Jun 27, 2024 - 3:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Favorable Strategic Partnering with Leading GLP-1 Players

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield positive results, not just in the potential treatment of diabetes but also in weight management, which has been directly linked to diabetes… The company recently received independent third-party ethics review…

InvestorNewsBreaks

NewsBreak Category: MissionIR

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions